U.S., April 9 -- ClinicalTrials.gov registry received information related to the study (NCT06915246) titled 'A Study of Carmustine With and Without Ethanol in Subjects With Lymphoma' on April 01.
Brief Summary: A phase 2 multicenter study of VI-0609 vs BiCNU in the BEAM high-intensity conditioning regimen for AHCT in subjects with lymphomas.
Study Start Date: March 12
Study Type: INTERVENTIONAL
Condition:
Lymphoma Undergoing Autologous Hematopoietic Cell Transplantation
Intervention:
DRUG: VI-0609
Carmustine with Propylene Glycol
DRUG: BiCNU
Carmustine with Ethanol
Recruitment Status: RECRUITING
Sponsor: VIVUS LLC
Published by HT Digital Content Services with permission from Health Daily Digest....